Vanda Pharmaceuticals (VNDA)
(Delayed Data from NSDQ)
$5.24 USD
+1.19 (29.38%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $5.30 +0.06 (1.15%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: -- |
3/2024 | $0.05 | 0.00% |
Earnings Summary
For their last quarter, Vanda Pharmaceuticals (VNDA) reported earnings of -$0.04 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 55.56%. Look out for VNDA's next earnings release expected on May 01, 2024. For the next earning release, we expect the company to report earnings of $0.05 per share, reflecting a year-over-year decrease of 16.67%.
Earnings History
Price & Consensus
Zacks News for VNDA
Vanda Pharmaceuticals (VNDA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
VNDA: What are Zacks experts saying now?
Zacks Private Portfolio Services